In Vitro Diagnostics Market is Expected to Reach $119.4 billion | MarketsandMarkets™ Chicago, April 16, 2024 (GLOBE NEWSWIRE) -- In Vitro Diagnostics market in terms of revenue was estimated to be worth $85.2 billion in 2024 and is poised to reach $119.4 billion by 2029, growing at...

Gastric Cancer Diagnostic Procedure Market Size Forecasts at 6.5% CAGR during (2022-2028) - Deep Dive Analysis of 18+ Countries across 5 Key Regions, 50+ Companies Scrutinized | The Insight Partners New York, March 02, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Gastric Cancer Diagnostic Procedure Market Size, Share, Growth, Trends and Global Forecasts to 2028 - COVID-19 Impact...

Medical Device Testing Market Size & Share to Surpass $12.94 Bn by 2028 | Vantage Market Research WASHINGTON, Nov. 27, 2022 (GLOBE NEWSWIRE) -- Vantage Market research has a newly released expansive study titled Global Medical Device Testing Market which guarantees you will remain better...

Zyomyx Receives $7.5 Million From UNITAID to Launch Rapid, Service-Free Point-of-Care CD4 Test FREMONT, Calif., March 26, 2014 (GLOBE NEWSWIRE) -- Zyomyx, Inc. has been awarded US$7.5 million from UNITAID to commercialize its quantitative MyT4™ point-of-care CD4 test, designed to guide...

Zyomyx Receives CE Mark for Its New MyT4(TM) Point-of-Care CD4 Test FREMONT, Calif., Jan. 9, 2014 (GLOBE NEWSWIRE) -- Zyomyx, Inc., a provider of innovative point-of-care diagnostic tests, announced today that it received the CE Mark for its MyT4™ point-of-care...